Long‐term remission of recurrent parvovirus‐B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion
暂无分享,去创建一个
[1] M. Mihatsch,et al. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] S. Choi,et al. A Case of Persistent Anemia in a Renal Transplant Recipient: Association with Parvovirus B19 Infection , 2002, Scandinavian journal of infectious diseases.
[3] E. Kraus,et al. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature , 2000, Clinical transplantation.
[4] D. Middleton,et al. Parvovirus B19 in kidney transplant patients. , 2000, Transplantation.
[5] P. Li,et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] F. Keller,et al. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] J. Saldanha,et al. Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture , 1996, British journal of haematology.
[8] Y. Yoto,et al. Large‐scale screening for human parvovirus B19 DNA in clinical specimens by dot blot hybridization and polymerase chain reaction , 1995, Journal of medical virology.
[9] Y. Yoto,et al. Incidence of human parvovirus B19 DNA detection in blood donors , 1995, British journal of haematology.
[10] M. Brophy,et al. Acute Renal Failure After Administration of Intravenous Immunoglobulin: Review of the Literature and Case Report , 1995, Pharmacotherapy.
[11] M. Rudnick,et al. Acute renal failure after intravenous immunoglobulin therapy. , 1994, The Journal of rheumatology.
[12] N. Young,et al. Erythrocyte P antigen: cellular receptor for B19 parvovirus. , 1993, Science.
[13] T. Starzl,et al. PARVOVIRUS B19 INFECTION IN PEDIATRIC TRANSPLANT PATIENTS , 1993, Transplantation.
[14] P. Simmonds,et al. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction , 1993, Journal of clinical microbiology.
[15] Y. Yoto,et al. Retrospective study on the influence of human parvovirus B19 infection among children with malignant diseases. , 1993, Acta haematologica.
[16] P. Ao. Renal failure and intravenous immunoglobulin. , 1992 .
[17] A. Phillips. Renal failure and intravenous immunoglobulin. , 1992, Clinical nephrology.
[18] T. Török. Parvovirus B19 and human disease. , 1992, Advances in internal medicine.
[19] B. Piraino,et al. Pulmonary and renal toxicity of intravenous immunoglobulin. , 1991, Clinical nephrology.
[20] D. W. Jenkins,et al. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. , 1989, The New England journal of medicine.
[21] B. Cohen,et al. The prevalence of antibody to human parvovirus B19 in England and Wales. , 1988, Journal of medical microbiology.